• About
  • Subscribe
  • Advertise
  • Contact
Sunday, May 18, 2025
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home News

Guide Dogs NSW/ACT makes ‘difficult decision’ over CFEH future

by Staff Writer
May 1, 2025
in Company updates & acquisitions, Local, News, Ophthalmic insights
Reading Time: 3 mins read
A A
CFEH clinician Janelle Tong with a patient at the Glaucoma Management Clinic. Image: CFEH.

CFEH clinician Janelle Tong with a patient at the Glaucoma Management Clinic. Image: CFEH.

Share on FacebookShare on Twitter

The Centre for Eye Health (CFEH) is phasing out its clinical service for patients, in a “difficult decision” from its main backer, Guide Dogs NSW/ACT, to transition funding away from early detection services.

The decision was announced 29 April 2025, and as a result, CFEH will be transitioning all existing patients “to appropriate alternative pathways”. Effective 1 May 2025, the body will no longer be accepting any new referrals.

Sarah Holland. Image: CFEH

“Where possible, all patients will be seen for a final review appointment before their records and ongoing care are transferred to a clinically appropriate alternate care provider,” a statement said.

CFEH was established in 2009 as a joint initiative between Guide Dogs NSW/ACT and UNSW.

In 2022, Insight reported Guide Dogs NSW/ACT invested around $3 million annually in CFEH to help reduce eye disease prevalence through early detection services at no cost to NSW patients. With an extensive database, CFEH also performed research and offers education opportunities for optometrists.

That same year, the CFEH announced a revamp of its operating model, with inaugural director Professor Michael Kalloniatis departing and Ms Sarah Holland appointed as general manager.

Guide Dogs NSW/ACT have stated this latest decision, made after careful consideration of multiple options, enabled it to focus resources on supporting people with permanent changes to their vision earlier in their journey, ensuring improved outcomes and access to critical services.

The organisation wants to increase its scope of service offerings in the low vision space and put more emphasis on social change in alignment with its priorities for 2030 and beyond, a note on the CFEH website said.

Since CFEH’s inception 15 years ago, the optometric industry has undergone significant advancement, the statement said.

“Optometrists in the community have greater access to imaging instruments and technology, and vastly improved diagnostic skills meaning they are well-equipped to provide care for many of the centre’s existing patients,” the statement said.

For patients requiring ophthalmology care, CFEH is working with industry stakeholders to identify and develop safe and sustainable tertiary care options.

Guide Dogs NSW/ACT will be providing additional support “to aid the safe transfer of existing patients”. This will happen in the form of transition funding and clinical equipment donation to support ongoing public ophthalmology and/or collaborative care models.

Reflecting on the lasting impact of CFEH, Holland said its clinical, education and research activities, developed over the past 15 years, cannot be overstated.

“We have collaborated on new clinical pathways with ophthalmology, played a part in shaping the future of optometry in Australia though our education activities, and contributed significantly to the evidence-base around ocular disease,” she said.

“As a team we are incredibly proud of everything we have achieved, and we will continue to support our community optometry colleagues as we transition our patients. The next 12 months will also see us continuing to work with our external stakeholders with an aim of developing sustainable, collaborative pathways for those requiring public ophthalmological care”.

Referrers and patients can access some FAQs here.

More reading

CFEH ‘redefining approach’ as director Prof Michael Kalloniatis departs

Centre for Eye Health appoints general manager to lead new operating model

Glaucoma suspects: More frequent reviews cost Australian health system less

Related Posts

Dr Lourens van Zyl recently switched to Blink eye drops in his clinic. Images: B+L.

Bausch + Lomb’s blinking success

by Staff Writer
May 17, 2025

Every second counts in Dr Lourens van Zyl’s busy Perth clinic, motivating him to switch to a new lubricating eye...

The cost of intravitreal eye injections to manage macular degeneration can discourage many older Australians from continuing treatment. Image: Rose Makin/stock.adobe.com.

Special Report: Intravitreal injections and bulk billing – good for business

by Rob Mitchell
May 16, 2025

Frequent intravitreal injections are vital to help many older Australians keep their eyesight, but the costs can be prohibitive. Insight...

A scene from the movie My Eyes, featuring optometrist Tsu Shan Chambers (right). Image: FanForce Films.

My Eyes film starring Australian optometrist set to open in theatres

by Staff Writer
May 16, 2025

A film highlighting the remarkable journey of a Australian mother determined to save her daughter’s eyesight, and starring a practising...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited